Breaking News Instant updates and real-time market news.

PCRX

Pacira

$48.65

1.25 (2.64%)

06:23
03/21/17
03/21
06:23
03/21/17
06:23

Pacira price target raised to $59 from $54 at Barclays

Barclays analyst Douglas Tsao raised his price target for Pacira Pharmaceuticals to $59 saying he left last week's American Academy of Orthopaedic Surgeons conference with increased confidence that the company's Exparel will sustain its recent commercial momentum. The analyst expects the pain treatment's sales will double in the coming years. He keeps an Overweight rating on Pacira.

PCRX Pacira
$48.65

1.25 (2.64%)

03/02/17
JEFF
03/02/17
NO CHANGE
Target $60
JEFF
Buy
Pacira price target raised to $60 from $53 at Jefferies
Jefferies analyst David Steinberg raised his price target for Pacira Pharmaceuticals to $60 saying the "much anticipated" and positive total knee arthroplasty study readout should "help considerably" with hospital payers. Pacira "looks to be playing offense in 2017," the analyst writes. He keeps a Buy rating on the shares.
03/02/17
JANY
03/02/17
DOWNGRADE
Target $38
JANY
Sell
Pacira downgraded to Sell from Neutral at Janney Capital
Janney Capital analyst Ken Trbovich downgraded Pacira to Sell from Neutral, statin that its guidance suggests no meaningful change in the outlook for Exparel sales this year. While the company also announced positive results from its Phase 4 study of Exparel in total knee replacement surgery, it may take "years" for the company to fully exploit this commercially, said Trbovich, who raised his fair value estimate on the stock to $38 from $34.
03/02/17
03/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kite Pharma (KITE) downgraded to Neutral from Buy at Citi with analyst Robyn Karnauskas saying this week's rally on the "strong data" price a lot of value into the shares. The analyst expects approval of axicabtagene and estimates worldwide peak sales of $1.7B, but sees little share upside from the pipeline in the near-term. She raised her price target for Kite shares to $87 from $62. 2. Apache (APA) downgraded to Underweight from Equal Weight at Barclays with analyst Thomas Driscoll saying he expects the company's 2018 oil volumes to fall below 2016 levels. He cut his price target for the shares to $50 from $56. 3. American Eagle (AEO) downgraded to Neutral from Buy at BofA/Merrill with analyst Stephen Albert citing disappointing first quarter comparable-store sales guidance. 4. TripAdvisor (TRIP) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Olson saying estimates may move lower as the company potentially increases investment in re-education. Olson thinks TripAdvisor shares may be range-bound through the remainder of the year and he lowered his price target for the stock to $47 from $60. 5. Pacira (PCRX) downgraded to Sell from Neutral at Janney Capital with analyst Ken Trbovich stating that its guidance suggests no meaningful change in the outlook for Exparel sales this year. While the company also announced positive results from its Phase 4 study of Exparel in total knee replacement surgery, it may take "years" for the company to fully exploit this commercially, said Trbovich, who raised his fair value estimate on the stock to $38 from $34. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
PIPR
03/14/17
NO CHANGE
Target $60
PIPR
Overweight
Piper more confident in Pacira after surgeon survey
Piper Jaffray analyst David Amsellem says his firm's survey of 29 orthopedic surgeons reinforces his confidence that Pacira Pharmaceuticals will be able to drive sustainable long-term volume growth for Exparel. Out of the 29 respondents, 83% noted that the data from the total knee arthroplasty study would result in them viewing Exparel's efficacy profile at least slightly more favorably, Amsellem tells investors in a research note. He believes Pacira is trading at an attractive risk/reward profile and reiterates an Overweight rating on the name with a $60 price target.

TODAY'S FREE FLY STORIES

TERP

TerraForm Power

$13.58

0.62 (4.78%)

05:06
10/19/17
10/19
05:06
10/19/17
05:06
Initiation
TerraForm Power initiated  »

TerraForm Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$55.77

0.71 (1.29%)

05:04
10/19/17
10/19
05:04
10/19/17
05:04
Recommendations
Abbott analyst commentary  »

Abbott price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$187.15

-10.63 (-5.37%)

05:00
10/19/17
10/19
05:00
10/19/17
05:00
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

MERC

Mercer

$13.50

-0.05 (-0.37%)

04:58
10/19/17
10/19
04:58
10/19/17
04:58
Upgrade
Mercer rating change  »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

ANGI

Angie's List

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Upgrade
Angie's List rating change  »

Angie's List…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GWW

Grainger

$208.81

3.39 (1.65%)

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Downgrade
Grainger rating change  »

Grainger downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

, NUVA

NuVasive

$54.18

0.47 (0.88%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Downgrade
Mazor Robotics, NuVasive rating change  »

Mazor Robotics downgraded…

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

NUVA

NuVasive

$54.18

0.47 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/13 EIA Natural…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/18 Fed Balance…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/9 Money Supply…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

, IAC

IAC

$124.60

-0.55 (-0.44%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Jefferies Internet analysts hold an analyst/industry conference call »

Internet Analysts…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

IAC

IAC

$124.60

-0.55 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 08

    Nov

  • 09

    Nov

UBS

UBS

$17.26

0.02 (0.12%)

, CME

CME Group

$136.37

0.18 (0.13%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Futures Industry Association to hold an expo »

33rd Annual FIA Futures…

UBS

UBS

$17.26

0.02 (0.12%)

CME

CME Group

$136.37

0.18 (0.13%)

NDAQ

Nasdaq

$74.60

-0.11 (-0.15%)

ICE

IntercontinentalExchange

$68.20

0.03 (0.04%)

CBOE

CBOE Holdings

$109.59

0.06 (0.05%)

BAC

Bank of America

$26.48

0.28 (1.07%)

GS

Goldman Sachs

$242.03

5.94 (2.52%)

JPM

JPMorgan

$97.99

0.37 (0.38%)

CS

Credit Suisse

$15.91

-0.11 (-0.69%)

C

Citi

$73.12

0.93 (1.29%)

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

MS

Morgan Stanley

$50.15

1.03 (2.10%)

WFC

Wells Fargo

$53.41

0.22 (0.41%)

AMTD

TD Ameritrade

$47.54

0.32 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 20

    Nov

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VPG

Vishay Precision

$24.40

0.55 (2.31%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Vishay Precision management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 07

    Nov

SCS

Steelcase

$15.30

0.1 (0.66%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Steelcase management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

October Philadelphia Fed…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

SB

Safe Bulkers

$3.12

-0.01 (-0.32%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SNY

Sanofi

$49.53

-0.06 (-0.12%)

, PFE

Pfizer

$35.83

-0.37 (-1.02%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Drug Information Association to hold a conference »

Metrics in…

SNY

Sanofi

$49.53

-0.06 (-0.12%)

PFE

Pfizer

$35.83

-0.37 (-1.02%)

ALKS

Alkermes

$51.09

-0.39 (-0.76%)

LLY

Eli Lilly

$85.73

-0.33 (-0.38%)

BMY

Bristol-Myers

$63.70

-0.48 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

COST

Costco

$157.55

-0.83 (-0.52%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Costco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/15 Bloomberg…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Leading Indicators to be reported at 10:00 »

September Leading…

PLX

Protalix

$0.83

0.176 (26.91%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Protalix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

GNCA

Genocea

$1.43

-0.12 (-7.74%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Genocea management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.